TherapeuticsMD (TXMD) Total Debt (2010 - 2022)

TherapeuticsMD's Total Debt history runs 9 years deep, the most recent figure standing at $93.6 million for Q3 2022.

• Quarterly Total Debt fell 49.88% year-over-year to $93.6 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $93.6 million (down 49.88% YoY) and the FY2021 annual result came in at $188.3 million, down 20.79% from the prior year.
• Total Debt was $93.6 million for Q3 2022 at TherapeuticsMD, up from $90.8 million in the prior quarter.
• Across five years, Total Debt topped out at $243.8 million in Q2 2020 and bottomed at $73.1 million in Q2 2018.
• A 5-year average of $165.3 million and a median of $188.6 million in 2021 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2020 — Total Debt jumped 231.19% — and 2022, when it tumbled 51.0%.
• TherapeuticsMD's Total Debt stood at $73.4 million in 2018, then surged by 165.24% to $194.6 million in 2019, then rose by 22.13% to $237.7 million in 2020, then retreated by 20.79% to $188.3 million in 2021, then sank by 50.28% to $93.6 million in 2022.
• Business Quant data shows TXMD's Total Debt at $93.6 million in Q3 2022, $90.8 million in Q2 2022, and $202.9 million in Q1 2022.